Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Tirzepatide: How They Compare This is the comparison most people want
Drug Class Insights How the Long-acting GLP-1 Agonists Segment Led the GLP-1 Market
Market Segmentation By Drug Class The India GLP-1 Receptor Agonist Market is segmented by drug class into long-acting agonists, short-acting agonists, and combination therapies
/ Guangzhou Innogen Pharmaceutical Group Co., Ltd., Novo Nordisk A/S, PegBio Co., Ltd., Pfizer Inc., QL Biopharmaceutical Co., Ltd., Roche Holding AG, Sanofi S.A., Sciwind Biosciences Co., Ltd., Tonghua Dongbao Pharmaceutical Co., Ltd., Viking Therapeutics, Inc., Amgen Inc., BioLingus GmbH, D&D Pharmatech Inc., Gmax Biopharm LLC, Hanmi Pharmaceutical Co., Ltd., Vivani Medical, Inc., vTv Therapeutics Inc., Zealand Pharma A/S, Altimmune, Inc., Structure Therapeutics Inc
US$ 29.90
US$ 24.04
US$ 21.61
US$ 24.90
